Cat. No. 4942
Alternative Name: NK-104
Chemical Name: (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fl
Biological ActivitySynthetic inhibitor of HMG-CoA reductase (Ki = 1.7 nM). Lowers low-density lipoprotein (LDL) cholesterol levels. Displays minimal metabolism by cytochrome P450 enzymes, with little involvement of CYP3A4. Shown to improve cardiac function and survival in a rat model of hypertensive heart failure.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Saka et al (2006) Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure. J.Cardiovasc.Pharmacol. 47 770. PMID: 16810078.
Mukhtar et al (2005) Pitavastatin. Int.J.Clin.Pract. 59 239. PMID: 15854203.
Aoki et al (1997) Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung. 47 904. PMID: 9296275.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Pitavastatin calcium from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Pitavastatin calcium, supplier, NK-104, HMG, CoA, reductase, inhibitors, inhibits, synthetic, statins, Tocris Bioscience, HMG-CoA Reductase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Protein disulfide isomerase (PDI) inhibitor3-AP
Ribonucleotide reductase inhibitor; also an iron chelator
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.